Brief: Aptahem And Seattle Children’S Research Institute Partner To Study Experimental Sepsis Drug
13/06/2018 07:15
June 13 (Reuters) - APTAHEM AB APTA.TE :
* APTAHEM AB - APTAHEM AND SEATTLE CHILDREN’S RESEARCH
INSTITUTE
PARTNER TO STUDY EXPERIMENTAL SEPSIS DRUG
Source text: https://bit.ly/2sTEK4a
Further company coverage: APTA.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Aptahem AB
See all newsBrief: Aptahem Signs Non Binding Term Sheet For Development, Manufacturing And Distribution Of Apta-1 For Sepsis In Europe
Brief: Aptahem Receives Patent Approval In India For Patent Family 1
Brief: Aptahem Rights Issue Oversubscribed
Brief: Aptahem Enters Agreement With Granzer Regulatory Consulting
Brief: Aptahem Largest Shareholder Suggests Dr Bert Junno New Chairman